Adalat cc and Nitro-dur drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adalat cc (nifedipine) and Nitro-dur (nitroglycerin). Common drug interactions include blood pressure diastolic decreased among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Adalat cc and Nitro-dur. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Adalat cc?

Adalat cc has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 5,019 Adalat cc users. Check the latest studies of Adalat cc.

What is Nitro-dur?

Nitro-dur has active ingredients of nitroglycerin. eHealthMe is studying from 2,414 Nitro-dur users. Check the latest studies of Nitro-dur.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

11 people who take Adalat cc and Nitro-dur together, and have interactions are studied.

Adalat cc and Nitro-dur drug interactions.

What are the common drug interactions of Adalat Cc and Nitro-Dur, by gender? *:

female:

  1. Blood pressure diastolic decreased
  2. Cough
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pyrexia (fever)
  8. Breast cancer female

male:

  1. Pyrexia (fever)
  2. Hip fracture
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Fall
  6. Heart rate increased
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Pneumonia

What are the common drug interactions of Adalat Cc and Nitro-Dur, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood pressure diastolic decreased
  2. Cough
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pyrexia (fever)

40-49:

n/a

50-59:

  1. Cardiovascular disorder (heart diseases)
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Heart rate increased
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Pyrexia (fever)

60+:

  1. Hip fracture
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Fall
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Pneumonia
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 27.27%
  2. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 3 people, 27.27%
  3. Stable Angina (a constant chest pain): 1 person, 9.09%
  4. High Blood Cholesterol: 1 person, 9.09%
  5. Birth Control: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat cc and Nitro-dur?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adalat cc and Nitro-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adalat cc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitro-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat cc and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitro-dur and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine and nitroglycerin (the active ingredients of Adalat cc and Nitro-dur, respectively), and Adalat cc and Nitro-dur (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: